HomeAPGE • NASDAQ
add
Apogee Therapeutics Inc
Previous close
$71.90
Day range
$70.46 - $73.44
Year range
$26.20 - $84.56
Market cap
4.94B USD
Avg Volume
887.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 78.06M | 2.87% |
Net income | -69.39M | -3.23% |
Net profit margin | — | — |
Earnings per share | -1.03 | 14.17% |
EBITDA | -77.65M | -2.43% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 730.19M | 40.25% |
Total assets | 937.13M | 24.30% |
Total liabilities | 33.25M | -10.51% |
Total equity | 903.88M | — |
Shares outstanding | 68.85M | — |
Price to book | 5.44 | — |
Return on assets | -24.97% | — |
Return on capital | -25.86% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -69.39M | -3.23% |
Cash from operations | -62.69M | 7.42% |
Cash from investing | -288.63M | -722.48% |
Cash from financing | 374.95M | 745.32% |
Net change in cash | 23.64M | 2.72% |
Free cash flow | -40.44M | 9.71% |
About
Founded
2022
Headquarters
Website
Employees
261
